Sarepta Therapeutics (SRPT) Drops Portion of Proposal Seeking Increase in Preferred Shares
In a proxy filing, Sarepta Therapeutics (NASDAQ: SRPT) said it has withdrawn the portion of proposal four requesting an increase ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
